Market Overview:
The global phenylpropanolamine market is expected to grow at a CAGR of 3.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of respiratory diseases, increasing demand for veterinary drugs, and growing awareness about the benefits of phenylpropanolamine products. By type, the market is segmented into tablet, capsule, and syrup segments. The tablet segment is expected to account for a major share of the global phenylpropanolamine market in 2018. By application, the human segment accounted for a major share of the global phenylpropanolamine market in 2017 and is projected to grow at a higher CAGR during the forecast period from 2018 to 2030.
Product Definition:
Phenylpropanolamine (PPA) is a sympathomimetic drug which is used as a decongestant, bronchodilator, and appetite suppressant. It is most commonly marketed as the prescription drug Benzedrex. PPA may also be found in over-the-counter preparations such as Sudafed and Actifed.
Tablet:
Tablet is a form of oral dosage drug delivery that is represented by solid or crushed tablets. It’s the most common and traditional way to deliver drugs. The factors that propel the growth of this market include increasing demand for efficient & effective medications, rising geriatric population base, growing prevalence of chronic diseases such as diabetes and cardiovascular disorders along with an increase in awareness about generic medicines across developing countries.
Capsule:
Capsule is a small package containing drug substance and the shell or membrane that holds it. The type of capsule depends on the size and shape of the drug. Capsules are available in different sizes such as microcapsule, pellet, tablet, capsule (largest) and others. They are widely used for oral administration of drugs especially for controlled release in humans but also find applications in other fields like nutraceuticals & cosmetics among others.
Application Insights:
The application segment includes human and veterinary. In 2017, the human application dominated the market with a share of over 91%. The demand for phenylpropanolamine among humans is generally higher in developed countries such as U.S., Germany, France while it is more or less same in developing countries like India and China.
Phenylpropanolamine is used for its diuretic property to treat hypertension which helps in reducing bloat caused due to retention of watery fluid around the abdomen. It also has an effect on increasing blood pressure thus treating hypertension among animals as well as humans which makes it a suitable drug for veterinary use also known asauxiliary medicine or companion animal medication globally speaking owing to its high demand from pet owners across the world especially during summer season when weather conditions are favorable for taking walks/jogs outdoors thereby promoting sales of PPIs globally speaking.
Regional Analysis:
North America phenylpropanolamine market accounted for the largest share of over 40.0% in 2017. The region is expected to maintain its dominance during the forecast period on account of rising product consumption as a result of increasing number of manufacturing facilities and distribution channels in U.S., coupled with growing pet population.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing to rising disposable income, improving healthcare infrastructure, and expanding human pharmaceutical industry in emerging countries such as China, India, Thailand & South Korea among others.
Europe was estimated at USD X billion in 2017.
Growth Factors:
- Increasing demand for energy drinks and weight loss supplements
- Rising awareness about the benefits of phenylpropanolamine
- Growing number of research studies supporting the use of phenylpropanolamine
- Availability of a wide range of products containing phenylpropanolamine
- Increasing number of distributors and retailers offering these products
Scope Of The Report
Report Attributes
Report Details
Report Title
Phenylpropanolamine Market Research Report
By Type
Tablet, Capsule, Syrup
By Application
Human, Veterinary
By Companies
Riemser Pharma, Abbott, Gräub, Helicon, Eipico, Schazoo, GlaxoSmithKline (GSK), Roemmers, Armoxindo, Asuncion, Medlink, Sanofi-Aventis, Tempo Scan Pacific, Carinopharm, Meda, IBL Healthcare, Gracia Pharmindo
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
134
Number of Tables & Figures
94
Customization Available
Yes, the report can be customized as per your need.
Global Phenylpropanolamine Market Report Segments:
The global Phenylpropanolamine market is segmented on the basis of:
Types
Tablet, Capsule, Syrup
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Human, Veterinary
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Riemser Pharma
- Abbott
- Gräub
- Helicon
- Eipico
- Schazoo
- GlaxoSmithKline (GSK)
- Roemmers
- Armoxindo
- Asuncion
- Medlink
- Sanofi-Aventis
- Tempo Scan Pacific
- Carinopharm
- Meda
- IBL Healthcare
- Gracia Pharmindo
Highlights of The Phenylpropanolamine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet
- Capsule
- Syrup
- By Application:
- Human
- Veterinary
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Phenylpropanolamine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Phenylpropanolamine is a sympathomimetic amine. It is a prescription medication used to treat nasal congestion, hay fever, and other conditions.
Some of the major players in the phenylpropanolamine market are Riemser Pharma, Abbott, Gr¤ub, Helicon, Eipico, Schazoo, GlaxoSmithKline (GSK), Roemmers, Armoxindo, Asuncion, Medlink, Sanofi-Aventis, Tempo Scan Pacific, Carinopharm, Meda, IBL Healthcare, Gracia Pharmindo.
The phenylpropanolamine market is expected to register a CAGR of 3.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Phenylpropanolamine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Phenylpropanolamine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Phenylpropanolamine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Phenylpropanolamine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Phenylpropanolamine Market Size & Forecast, 2018-2028
4.5.1 Phenylpropanolamine Market Size and Y-o-Y Growth
4.5.2 Phenylpropanolamine Market Absolute $ Opportunity
Chapter 5 Global Phenylpropanolamine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Phenylpropanolamine Market Size Forecast by Type
5.2.1 Tablet
5.2.2 Capsule
5.2.3 Syrup
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Phenylpropanolamine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Phenylpropanolamine Market Size Forecast by Applications
6.2.1 Human
6.2.2 Veterinary
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Phenylpropanolamine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Phenylpropanolamine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Phenylpropanolamine Analysis and Forecast
9.1 Introduction
9.2 North America Phenylpropanolamine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Phenylpropanolamine Market Size Forecast by Type
9.6.1 Tablet
9.6.2 Capsule
9.6.3 Syrup
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Phenylpropanolamine Market Size Forecast by Applications
9.10.1 Human
9.10.2 Veterinary
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Phenylpropanolamine Analysis and Forecast
10.1 Introduction
10.2 Europe Phenylpropanolamine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Phenylpropanolamine Market Size Forecast by Type
10.6.1 Tablet
10.6.2 Capsule
10.6.3 Syrup
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Phenylpropanolamine Market Size Forecast by Applications
10.10.1 Human
10.10.2 Veterinary
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Phenylpropanolamine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Phenylpropanolamine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Phenylpropanolamine Market Size Forecast by Type
11.6.1 Tablet
11.6.2 Capsule
11.6.3 Syrup
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Phenylpropanolamine Market Size Forecast by Applications
11.10.1 Human
11.10.2 Veterinary
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Phenylpropanolamine Analysis and Forecast
12.1 Introduction
12.2 Latin America Phenylpropanolamine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Phenylpropanolamine Market Size Forecast by Type
12.6.1 Tablet
12.6.2 Capsule
12.6.3 Syrup
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Phenylpropanolamine Market Size Forecast by Applications
12.10.1 Human
12.10.2 Veterinary
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Phenylpropanolamine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Phenylpropanolamine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Phenylpropanolamine Market Size Forecast by Type
13.6.1 Tablet
13.6.2 Capsule
13.6.3 Syrup
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Phenylpropanolamine Market Size Forecast by Applications
13.10.1 Human
13.10.2 Veterinary
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Phenylpropanolamine Market: Competitive Dashboard
14.2 Global Phenylpropanolamine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Riemser Pharma
14.3.2 Abbott
14.3.3 Gräub
14.3.4 Helicon
14.3.5 Eipico
14.3.6 Schazoo
14.3.7 GlaxoSmithKline (GSK)
14.3.8 Roemmers
14.3.9 Armoxindo
14.3.10 Asuncion
14.3.11 Medlink
14.3.12 Sanofi-Aventis
14.3.13 Tempo Scan Pacific
14.3.14 Carinopharm
14.3.15 Meda
14.3.16 IBL Healthcare
14.3.17 Gracia Pharmindo
